Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupivacaine vs Lidocaine in Outpatient Hand Surgery
NCT01751347Phase 4Completed
- Sponsor
- University of British Columbia
- Start
- Feb 2013
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of bupivacaine in carpal tunnel syndrome (CTS) and trigger finger, sponsored by University of British Columbia. Primary endpoint: Amount of oral analgesic used post procedure at 2 weeks. Started Feb 2013; status: completed.
02
Drugs
bupivacaine
03
Conditions
carpal tunnel syndrome (CTS)trigger finger
Beyond the preview
Go deeper on NCT01751347.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01751347.